The effect of silicon-on-insulator ͑SOI͒ substrate type and surface silicon thickness on extended defect evolution due to silicon ion implantation has been investigated. Nonamorphizing silicon implants ranging from 15 to 48.5 keV, 1 ϫ 10 14 cm
As bulk silicon approaches the limits of scaling of complementary metal-oxide-semiconductor ͑CMOS͒ devices, silicon-oninsulator ͑SOI͒ continues to be looked at as an alternative.
1 SOI allows for advantages in speed, power reduction, and parasitic effects. 2 However, adequate models for predicting dopant diffusion in SOI need to be developed so that future devices may be developed. 3 Dopant segregation in the proximity of the surface silicon/buried oxide ͑BOX͒ interface has been observed by a number of investigators. 4, 5, 6 Diffusion of dopants in silicon is known to be strongly affected by point defect populations produced by ion implantation. 7 The presence of the surface silicon/BOX interface must be accounted for, in addition to the surface, as a location for interstitial recombination. Thus, it is imperative to understand point defect interactions with the surface silicon/BOX interface as SOI devices are scaled into the fully depleted regime.
While quality of separation by implantation of oxygen ͑SIMOX͒ material has made great strides since its conception, 8 there is concern over differences in quality of a synthetic BOX ͑e.g., SIMOX͒ vs. a grown thermal BOX ͑e.g., SOITEC͒. 9 Due to the large oxygen doses used for BOX formation in the SIMOX process, residual oxygen is expected to be left in the surface silicon layer. The excess oxygen could theoretically serve as traps for interstitials, thus affecting dopant diffusion and interstitial recombination. The current study extends from previous studies 10, 11 by investigating the dependence of point defect populations on the type of surface silicon/BOX interface ͑e.g., SIMOX or SOITEC͒, as well as proximity to the interface. This is accomplished by monitoring trapped interstitials within extended defects ͑e.g., ͕311͖ defects and dislocation loops͒. The study focuses specifically on ͕311͖ defect formation rather than both ͕311͖ and dislocation loop formation.
Experimental
In the experiment, Czochralski, SIMOX, and SOITEC wafers ͑p-type, 200 mm, ͕001͖͒ having a BOX thickness of 1300 Å were used. Thinning of the surface silicon layer from 1450 to 750 Å was done for selected SOI wafers using oxidation and then etching with dilute hydrofluoric acid. 28 Si ϩ implants were performed at a nonamorphizing dose of 1 ϫ 10 14 cm Ϫ2 with a 7°tilt and 22°twist angle. Implant energies were performed at 15, 30, and 48.5 keV for the 1450 Å and bulk specimens. The 750 Å specimens were implanted at 15 and 30 keV, but not at 48.5 keV due to concerns over dose loss to the BOX. Thermal processing was performed in a Thermolyne quartz tube furnace under a nitrogen ambient at 750°C for times ranging from 5 min to 1 h. Plan-view transmission electron microscopy ͑PTEM͒ SOI specimens were prepared in the following sequence: back-side grinding using 15 m alumina slurry, back-side etching using HNO3:HF 3:1, buffered oxide etching ͑6:1͒. The buffered oxide etching step assisted with removal of the BOX; thus, it was not required for fabrication of bulk PTEM specimens. A JEOL 200CX transmission electron microscope with an accelerating voltage of 200 kV and emission current of 125 A was used to image the PTEM specimens. Weak-beam dark-field ͑WBDF͒ images were taken under g͑3g͒ conditions using a g 220 diffracted beam. Quantitative TEM ͑QTEM͒ was used to measure the concentration of trapped interstitials, defect density, and defect size.
Results

Figure 1 shows UT-Marlowe
12 simulations of the ion profiles for the Si ϩ implants. The projected range for the 15, 30, and 48.5 keV implants was measured to be 180, 330, and 550 Å, respectively. All the implants punch through into the BOX for the SOI specimens, but more severely for the 750 Å SOI. Integration of the profile confined to the surface silicon layer allows for calculation of the initial dose loss of Si ϩ ions to the BOX ͑Fig. 2͒. The 750 Å SOI loses approximately 3% of the implanted dose at 15 keV, 10% at 30 keV, and 30% at 48.5 keV. The dose loss for the 1450 Å SOI was approximately 1% at 30 keV and 3% at 48.5 keV. Figure 3 shows WBDF images for the 15 keV specimens after annealing for 5 and 15 min. There does not appear to be a difference between SOITEC and SIMOX for either the 750 or 1450 Å specimens. A high density of small dot defects appears at short times, which evolves into ͕311͖ defects in the 1450 Å and bulk as annealing proceeds. However, the 750 Å SOI appears to avoid growth of ͕311͖ defects above a certain length. Rather, the dot defects appear to be much more stable in the 750 Å SOI than ͕311͖ defects. Figure  4 shows the concentration of trapped interstitials in all extended defects. A slight enhancement in the decay of the trapped interstitial population occurs in the 750 Å SOI at longer times. However, as stated previously, no differences can be distinguished between SOI-TEC and SIMOX. Figure 5 shows PTEM images illustrating the extended defect evolution for the 30 keV, 1 ϫ 10 14 cm Ϫ2 SIMOX and bulk specimens after annealing 5 and 15 min. Once again, the microstructure appears similar between the SIMOX and bulk after annealing for 5 min. However, after 15 min the dot defects have evolved into ͕311͖ defects in the bulk, but not in the 750 Å SIMOX. The QTEM trapped interstitial data for the 30 keV specimens is shown in Fig. 6 . Despite a 10% initial dose loss in the 750 Å SOI, no decrease in the initial trapped interstitial population can be seen. As annealing proceeds, a significant enhancement in the decay rate of the trapped interstitial population in SOI is observed. This effect is further illustrated in Fig. 7 by quantifying the concentration of trapped interstitials within ͕311͖ defects only. The 750 Å SIMOX and SOITEC decay to the TEM detection limit of ϳ1 ϫ 10 11 cm Ϫ2 after annealing for 15 min. A decrease in trapped interstitials in ͕311͖s also appears in the 1450 Å specimens, but is not as dramatic as in the 750 Å. Figure 8 shows the average size of ͕311͖ defects in SOI and bulk. Growth of ͕311͖ defects appears in the 1450 Å SOI and bulk, but shrinkage is observed in the 750 Å SOI. On the contrary, the 750 Å SOI tends to favor dislocation loop formation over ͕311͖ defects, as seen in the micrographs in Fig. 5 . Figure 9 shows the PTEM micrographs for the 1450 Å SOI and bulk specimens implanted at 48.5 keV. As before, dot defects appear at early times, which then evolve into ͕311͖ defects in the bulk. However, a clear reduction in the ͕311͖ defect size and density can be seen in the 1450 Å SIMOX and SOITEC. The QTEM data appears in Fig. 10 and 11 . An enhancement in the decay rate is observed for the 1450 Å SOI, despite only a 3% dose loss from the implant. This enhancement is once again attributed to a reduction in the ͕311͖ population, shown in Fig. 11 . Figure 12 shows the average size of the ͕311͖ defects in the 1450 Å SOI and bulk. The ͕311͖s appear to reach a critical size of approximately 150 Å in the 1450 Å SOI, after which they begin to dissolve. Growth of the ͕311͖ defects continues in the bulk silicon to an average size above 300 Å.
Discussion
Comparison of the decay of the trapped interstitial population between SOI and bulk silicon agrees well with previous experiments. 10, 11 For ion and interstitial profiles confined to the surface silicon layer, little difference is seen between SOI and bulk. However, no measurable decrease in the initial trapped interstitial concentration is observed in the 750 Å SOI despite a 10% dose loss at 30 keV. A reduction in the initial trapped interstitial concentration has been previously observed for dose losses as low as 6%. 10, 11 The previous experiments also showed that an enhancement in the decay rate was not observed without more than a 13% dose loss. The instability of the ͕311͖ defect compared to the dislocation loop is the likely cause of these observations. This is a result of the lower dose used in the current experiment. A 1 ϫ 10 14 cm Ϫ2 Si ϩ dose in the energy range of 20-80 keV tends to form ͕311͖ defects, which mostly dissolve after approximately 1-1.5 h at 750°C. The 2 ϫ 10 14 cm Ϫ2 Si ϩ dose used in the previous experiments forms ͕311͖ defects, but these tend to unfault to form stable dislocation loops. The enhanced decay rate in the trapped interstitial concentration in SOI is a result of the enhanced dissolution of ͕311͖ defects in SOI. We discuss the affects of dose loss/implant energy, SOI thickness, and interface roughness later.
The most interesting observation from the data presented is that ͕311͖ defects do not go through the same growth process in SOI as in bulk silicon. This occurs despite minimal dose loss of interstitials to the buried oxide. Clearly, growth of ͕311͖ defects is observed in bulk silicon. However, the amount of elongation of ͕311͖ defects in SOI depends strongly on the surface silicon thickness. The average size of the ͕311͖ defects increases as the surface silicon layer thickness is increased. This leads to the following propositions. The ͕311͖ defect is known to reside along ͕311͖ planes and elongate in ͗110͘ directions. 13 For the ͗110͘ family of directions, six directions are inclined to the surface for a ͕001͖-oriented silicon crystal. The ͕311͖ defects are prevented from elongating into the buried oxide, because it is amorphous. Thus, the ͕311͖ defects which elongate inclined to the surface can only grow to a certain length before they are pinned by the BOX. This would depend on the implant energy and the surface silicon thickness. The higher the implant energy or the thinner the surface silicon layer, the smaller the size of ͕311͖ defects observed. This theory supports the results that have been presented.
There is one problem with the proposed theory; it does not account for ͕311͖ defects that elongate in the plane of the surface silicon layer. Those ͕311͖ defects still are expected to elongate to the same length as those in bulk silicon. However, this is not observed in the PTEM micrographs. This may indicate that ͕311͖ defects simply are not as stable in SOI as in bulk silicon.
14 Future experiments will set out to investigate the role of stress on ͕311͖ evolution in SOI due to differences in thermal expansion coefficients between silicon and SiO 2 .
The measured ''ϩ1'' value 15 for the initial trapped interstitial concentration in extended defects was not strongly affected, even when the ion profile overlapped the surface Si/BOX interface. However, there is typically a variation of 20% in QTEM measurements of ͕311͖ defects in Si. Thus, a variation in the ''ϩ1'' value between SOI and bulk is within the error of the measurements. The expected variation, based on simulation, in the ''ϩ1'' value as a function of surface Si thickness is shown in Fig. 13 . This value was obtained by subtracting the vacancy profile from the interstitial profile and integrating over the surface Si thickness. These values ignore outdiffusion of interstitials from the BOX into the surface Si layer. It shows that the ''ϩ1'' value does not vary significantly until the thickness is scaled below 450 Å for the 15 keV implant energy. For the 48.5 keV implant energy the ''ϩ1'' value begins to decrease significantly below a surface Si thickness of 1000 Å. From this, interstitial dose loss can be ruled out as the primary reason for the instability of ͕311͖s in SOI, at least for the surface Si thickness and implant energies used in this study. The easiest way to lose interstitials to the BOX is by increasing the implant energy, thus truncating more of the ion/ interstitial profiles. Interstitial dose loss has been attributed to the observance of reduced dislocation loop size in SOI. 11 Another mechanism that may affect interstitial decay from ͕311͖s is roughness of the surface Si/BOX interface. This has been suggested previously. 11 As the surface Si/BOX interface sees more of the dose, the roughness of the interface is likely to increase. This could increase the dangling bond and kink site densities, allowing more interstials to recombine. However, if this is the primary mechanism it is much stronger than observed in the previous experiment.
11
One final discussion with regard to the differences between SI-MOX and SOITEC interfaces is necessary. There is no distinguishable difference in the ability of the surface silicon/BOX interface of either material to allow interstitials to recombine or diffuse into the BOX. It seems obvious that the interfaces are more similar than may have been expected. A SOITEC buried oxide is a grown, thermal oxide, whereas a SIMOX buried oxide is a synthetic oxide. However, developments in SIMOX technology, such as the internal thermal oxidation ͑ITOX͒ process used to produce the wafers in this experiment, may yield an interface similar to a grown thermal oxide. If this is the case, then the results certainly make sense.
Conclusions
The effect of interface type ͑e.g., SIMOX or SOITEC͒ and surface silicon thickness on ͕311͖ defect evolution has been investigated via QTEM. We show that both SIMOX and SOITEC interfaces allow for similar defect evolution and recombination of trapped interstitials. A significant difference in ͕311͖ nucleation and growth in SOI is observed. Dose loss, SOI thickness, and interface roughness are proposed as mechanisms by which the ͕311͖ stability is reduced in SOI. ͕311͖ defects in SOI are not as stable and appear to favor formation of dislocation loops as the surface Si layer is thinned. The enhanced dissolution of ͕311͖s in SOI are believed to be the reason for enhancement in the decay of the trapped interstitial population for low dose losses. We will attempt to model the interface in the future in order to extract the recombination velocity of trapped interstitials at the surface silicon/BOX interface. Figure 13 . ''ϩ1'' value as a function of surface Si thickness for different implant energies used in the study.
